Congenital generalized lipodystrophy in Taiwan

Rai Hseng Hsu, Wei De Lin, Mei Chyn Chao, Hui Pin Hsiao, Siew Lee Wong, Pao Chin Chiu, Shao Yin Chu, Yu Yuan Ke, Beng Huat Lau, Yin Hsiu Chien, Wuh Liang Hwu, Fuu Jen Tsai, Chung Hsing Wang, Ni Chung Lee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Congenital generalized lipodystrophy (CGL) is a rare disorder characterized by scarce adipose tissue. This disease is distributed worldwide, but little is known about these patients in the Chinese population. Here, we delineate the phenotype and prognosis of CGL in our cohort. Methods: Patients diagnosed with CGL from 8 medical centers were reviewed. The initial presentation, laboratory findings, and molecular testing were retrospectively analyzed. Results: A total of 16 patients were analyzed, and the current median age was 3.5 years (range, 9 months-17.5 years). In all patients, molecular results confirmed BSCL2 mutation. c.782dupG (p.Ile262Hisfs*12) was the most common genotype identified. All patients had triangular faces and muscular hypertrophy. In addition, 75% presented with hepatomegaly, 19% had cardiomegaly, and 44% exhibited acanthosis nigricans. Developmental delay was noted in 5 out of 9 patients (56%) with a median developmental quotient (DQ)/intelligence quotient (IQ) of 61. Thirteen patients (81.3%) had high triglyceride levels. Eight patients received leptin analysis, and 7 of them (88%) had low leptin levels. One patient exclusively received a lipid-lowering drug, 4 patients were exclusively placed on a fat-restricted diet, 5 patients were administered combination therapy, and 5 patients received no treatment. Three patients (19%) who developed diabetes mellitus received both oral hypoglycemic agents and insulin. Three patients (19%) experienced loss of ambulation and died prematurely. Conclusion: Our findings highlight the uniqueness of the genotype and phenotype in our cohort. Further long-term surveillance for comorbidities is necessary for early detection and management of these patients.

Original languageEnglish
Pages (from-to)142-147
Number of pages6
JournalJournal of the Formosan Medical Association
Volume118
Issue number1P1
DOIs
Publication statusPublished - Jan 2019

Keywords

  • Congenital generalized lipodystrophy
  • Morbidity
  • Outcome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hsu, R. H., Lin, W. D., Chao, M. C., Hsiao, H. P., Wong, S. L., Chiu, P. C., ... Lee, N. C. (2019). Congenital generalized lipodystrophy in Taiwan. Journal of the Formosan Medical Association, 118(1P1), 142-147. https://doi.org/10.1016/j.jfma.2018.02.003

Congenital generalized lipodystrophy in Taiwan. / Hsu, Rai Hseng; Lin, Wei De; Chao, Mei Chyn; Hsiao, Hui Pin; Wong, Siew Lee; Chiu, Pao Chin; Chu, Shao Yin; Ke, Yu Yuan; Lau, Beng Huat; Chien, Yin Hsiu; Hwu, Wuh Liang; Tsai, Fuu Jen; Wang, Chung Hsing; Lee, Ni Chung.

In: Journal of the Formosan Medical Association, Vol. 118, No. 1P1, 01.2019, p. 142-147.

Research output: Contribution to journalArticle

Hsu, RH, Lin, WD, Chao, MC, Hsiao, HP, Wong, SL, Chiu, PC, Chu, SY, Ke, YY, Lau, BH, Chien, YH, Hwu, WL, Tsai, FJ, Wang, CH & Lee, NC 2019, 'Congenital generalized lipodystrophy in Taiwan', Journal of the Formosan Medical Association, vol. 118, no. 1P1, pp. 142-147. https://doi.org/10.1016/j.jfma.2018.02.003
Hsu, Rai Hseng ; Lin, Wei De ; Chao, Mei Chyn ; Hsiao, Hui Pin ; Wong, Siew Lee ; Chiu, Pao Chin ; Chu, Shao Yin ; Ke, Yu Yuan ; Lau, Beng Huat ; Chien, Yin Hsiu ; Hwu, Wuh Liang ; Tsai, Fuu Jen ; Wang, Chung Hsing ; Lee, Ni Chung. / Congenital generalized lipodystrophy in Taiwan. In: Journal of the Formosan Medical Association. 2019 ; Vol. 118, No. 1P1. pp. 142-147.
@article{24156ed2457948aaa83d36ab876cdd84,
title = "Congenital generalized lipodystrophy in Taiwan",
abstract = "Background: Congenital generalized lipodystrophy (CGL) is a rare disorder characterized by scarce adipose tissue. This disease is distributed worldwide, but little is known about these patients in the Chinese population. Here, we delineate the phenotype and prognosis of CGL in our cohort. Methods: Patients diagnosed with CGL from 8 medical centers were reviewed. The initial presentation, laboratory findings, and molecular testing were retrospectively analyzed. Results: A total of 16 patients were analyzed, and the current median age was 3.5 years (range, 9 months-17.5 years). In all patients, molecular results confirmed BSCL2 mutation. c.782dupG (p.Ile262Hisfs*12) was the most common genotype identified. All patients had triangular faces and muscular hypertrophy. In addition, 75{\%} presented with hepatomegaly, 19{\%} had cardiomegaly, and 44{\%} exhibited acanthosis nigricans. Developmental delay was noted in 5 out of 9 patients (56{\%}) with a median developmental quotient (DQ)/intelligence quotient (IQ) of 61. Thirteen patients (81.3{\%}) had high triglyceride levels. Eight patients received leptin analysis, and 7 of them (88{\%}) had low leptin levels. One patient exclusively received a lipid-lowering drug, 4 patients were exclusively placed on a fat-restricted diet, 5 patients were administered combination therapy, and 5 patients received no treatment. Three patients (19{\%}) who developed diabetes mellitus received both oral hypoglycemic agents and insulin. Three patients (19{\%}) experienced loss of ambulation and died prematurely. Conclusion: Our findings highlight the uniqueness of the genotype and phenotype in our cohort. Further long-term surveillance for comorbidities is necessary for early detection and management of these patients.",
keywords = "Congenital generalized lipodystrophy, Morbidity, Outcome",
author = "Hsu, {Rai Hseng} and Lin, {Wei De} and Chao, {Mei Chyn} and Hsiao, {Hui Pin} and Wong, {Siew Lee} and Chiu, {Pao Chin} and Chu, {Shao Yin} and Ke, {Yu Yuan} and Lau, {Beng Huat} and Chien, {Yin Hsiu} and Hwu, {Wuh Liang} and Tsai, {Fuu Jen} and Wang, {Chung Hsing} and Lee, {Ni Chung}",
year = "2019",
month = "1",
doi = "10.1016/j.jfma.2018.02.003",
language = "English",
volume = "118",
pages = "142--147",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "1P1",

}

TY - JOUR

T1 - Congenital generalized lipodystrophy in Taiwan

AU - Hsu, Rai Hseng

AU - Lin, Wei De

AU - Chao, Mei Chyn

AU - Hsiao, Hui Pin

AU - Wong, Siew Lee

AU - Chiu, Pao Chin

AU - Chu, Shao Yin

AU - Ke, Yu Yuan

AU - Lau, Beng Huat

AU - Chien, Yin Hsiu

AU - Hwu, Wuh Liang

AU - Tsai, Fuu Jen

AU - Wang, Chung Hsing

AU - Lee, Ni Chung

PY - 2019/1

Y1 - 2019/1

N2 - Background: Congenital generalized lipodystrophy (CGL) is a rare disorder characterized by scarce adipose tissue. This disease is distributed worldwide, but little is known about these patients in the Chinese population. Here, we delineate the phenotype and prognosis of CGL in our cohort. Methods: Patients diagnosed with CGL from 8 medical centers were reviewed. The initial presentation, laboratory findings, and molecular testing were retrospectively analyzed. Results: A total of 16 patients were analyzed, and the current median age was 3.5 years (range, 9 months-17.5 years). In all patients, molecular results confirmed BSCL2 mutation. c.782dupG (p.Ile262Hisfs*12) was the most common genotype identified. All patients had triangular faces and muscular hypertrophy. In addition, 75% presented with hepatomegaly, 19% had cardiomegaly, and 44% exhibited acanthosis nigricans. Developmental delay was noted in 5 out of 9 patients (56%) with a median developmental quotient (DQ)/intelligence quotient (IQ) of 61. Thirteen patients (81.3%) had high triglyceride levels. Eight patients received leptin analysis, and 7 of them (88%) had low leptin levels. One patient exclusively received a lipid-lowering drug, 4 patients were exclusively placed on a fat-restricted diet, 5 patients were administered combination therapy, and 5 patients received no treatment. Three patients (19%) who developed diabetes mellitus received both oral hypoglycemic agents and insulin. Three patients (19%) experienced loss of ambulation and died prematurely. Conclusion: Our findings highlight the uniqueness of the genotype and phenotype in our cohort. Further long-term surveillance for comorbidities is necessary for early detection and management of these patients.

AB - Background: Congenital generalized lipodystrophy (CGL) is a rare disorder characterized by scarce adipose tissue. This disease is distributed worldwide, but little is known about these patients in the Chinese population. Here, we delineate the phenotype and prognosis of CGL in our cohort. Methods: Patients diagnosed with CGL from 8 medical centers were reviewed. The initial presentation, laboratory findings, and molecular testing were retrospectively analyzed. Results: A total of 16 patients were analyzed, and the current median age was 3.5 years (range, 9 months-17.5 years). In all patients, molecular results confirmed BSCL2 mutation. c.782dupG (p.Ile262Hisfs*12) was the most common genotype identified. All patients had triangular faces and muscular hypertrophy. In addition, 75% presented with hepatomegaly, 19% had cardiomegaly, and 44% exhibited acanthosis nigricans. Developmental delay was noted in 5 out of 9 patients (56%) with a median developmental quotient (DQ)/intelligence quotient (IQ) of 61. Thirteen patients (81.3%) had high triglyceride levels. Eight patients received leptin analysis, and 7 of them (88%) had low leptin levels. One patient exclusively received a lipid-lowering drug, 4 patients were exclusively placed on a fat-restricted diet, 5 patients were administered combination therapy, and 5 patients received no treatment. Three patients (19%) who developed diabetes mellitus received both oral hypoglycemic agents and insulin. Three patients (19%) experienced loss of ambulation and died prematurely. Conclusion: Our findings highlight the uniqueness of the genotype and phenotype in our cohort. Further long-term surveillance for comorbidities is necessary for early detection and management of these patients.

KW - Congenital generalized lipodystrophy

KW - Morbidity

KW - Outcome

UR - http://www.scopus.com/inward/record.url?scp=85042328704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042328704&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2018.02.003

DO - 10.1016/j.jfma.2018.02.003

M3 - Article

C2 - 29478747

AN - SCOPUS:85042328704

VL - 118

SP - 142

EP - 147

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 1P1

ER -